8 Reasons for less weight loss with GLP1 RAs for T2D could include use of insulin or other obesity-promoting medications, concerns over hypoglycemia, decreased glycosuria, microbiome variation, genetic predisposition towards weight gain, and differences in endogenous GLP-1 pathways in the brain and other tissues
Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society
CC: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Software, Supervision, Validation, Visualization, Writing original draft, Writing review and editing
Un estudio (en ingls) similar publicado el ao pasado en Diabetes, Obesity and Metabolism encontr que cambiar de una dosis semanal de GLP-1 a una dosis cada dos semanas ayud a las personas a mantener aproximadamente el 75% de su prdida de peso
Glutathione is a highly effective antioxidant with wide-ranging benefits, especially when combined with NAC and Vitamin C